SheilaAnnPrindivilleMD

PubMed

• 1 citations
  A call to action to advance patient-focused and decentralized clinical trials.
  R Donald Harvey, Therica M Miller, Patricia A Hurley, Ramya Thota, Lora J Black, Suanna S Bruinooge, Leigh M Boehmer, Mark E Fleury, Jasmine Kamboj, Mujahid A Rizvi, B...> ;Cancer. 2024 Apr 15
• The National Cancer Institute's Clinical Trials Innovation Unit.
  Michael J Morris, Sheila Prindiville> ;Clinical Advances in Hematology & Oncology. 2023 Dec 1
• 2 citations
  Approach for reporting master protocol study designs on ClinicalTrials.gov: qualitative analysis.
  Rebecca J Williams, Heather D Dobbins, Tony Tse, Sandy D Chon, David Loose, Gisele A Sarosy, Sheila A Prindiville, Frank W Rockhold, Deborah A Zarin> ;BMJ. 2022 Jun 10
• 3 citations
  Patterns of Enrollment in Cancer Treatment Trials During the COVID-19 Pandemic at National Cancer Institute-Designated Cancer Centers.
  Sheila A Prindiville, Gisele A Sarosy, David Loose, Henry Ciolino, James H Doroshow> ;Cancer Journal. 2022 Mar 25
• 15 citations
  COVID-19, Social Justice, and Clinical Cancer Research.
  James H. Doroshow, Sheila A. Prindiville, Worta McCaskill-Stevens, Margaret M. Mooney, Patrick J. Loehrer> ;Journal of the National Cancer Institute. 2021 Oct 1
• 2 citations
  Characteristics of Breast Ducts in Normal-Risk and High-risk Women and Their Relationship to Ductal Cytologic Atypia.
  David N. Danforth, Armando C. Filie, Andrew C. Warner, George W. Wright, Zhonghe Sun, Thomas Ried, Christine T. McGowan, Sheila A. Prindiville> ;Cancer Prevention Research. 2020 Aug 4
• 6 citations
  The National Cancer Institute and Department of Veterans Affairs Interagency Group to Accelerate Trials Enrollment (NAVIGATE): A federal collaboration to improve cance...
  Sara J. Schiller, Colleen Shannon, Mary Brophy, Andrea Denicoff, Marjorie J. Good, Sheila A. Prindiville, Grant D. Huang> ;Seminars in Oncology. 2019 Aug 1
• 58 citations
  Research priorities, measures, and recommendations for assessment of tobacco use in clinical cancer research
  Stephanie R. Land, Benjamin A. Toll, Carol M. Moinpour, Sandra A. Mitchell, Jamie S. Ostroff, Dorothy K. Hatsukami, Sonia A. Duffy, Ellen R. Gritz, Nancy A. Rigotti, T...> ;Clinical Cancer Research. 2016 Apr 15
• 6 citations
  An Improved Breast Epithelial Sampling Method for Molecular Profiling and Biomarker Analysis in Women at Risk for Breast Cancer
  David N. Danforth, Andrew C. Warner, Darawalee Wangsa, Thomas Ried, Dominik M. Duelli, Armando C. Filie, Sheila A. Prindiville> ;Breast Cancer. 2015 Jun 8
• 44 citations
  Relationships between computer-extracted mammographic texture pattern features and BRCA1/2 mutation status: a cross-sectional study
  Gretchen L. Gierach, Hui Li, Jennifer T. Loud, Mark H. Greene, Catherine Chow, Li Lan, Sheila A. Prindiville, Jennifer Eng-Wong, Peter W. Soballe, Claudia Giambartolom...> ;Breast Cancer Research. 2014 Aug 23
• 23 citations
  Implementation of Timeline Reforms Speeds Initiation of National Cancer Institute–Sponsored Trials
  Jeffrey S. Abrams, Margaret M. Mooney, James A. Zwiebel, Edward L. Korn, Steven H. Friedman, Shanda Finnigan, Patricia R. Schettino, Andrea Denicoff, Martha Kruhm, Mik...> ;Journal of the National Cancer Institute. 2013 Jul 3
• 81 citations
  Single-Cell Genetic Analysis of Ductal Carcinoma in Situ and Invasive Breast Cancer Reveals Enormous Tumor Heterogeneity yet Conserved Genomic Imbalances and Gain of M...
  Kerstin Heselmeyer-Haddad, Lissa Y. Berroa Garcia, Amanda Bradley, Clarymar Ortiz-Melendez, Woei-Jyh Lee, Rebecca Christensen, Sheila A. Prindiville, Kathleen A. Calzo...> ;The American Journal of Pathology. 2012 Nov 1
• A phase II study of intermittent sorafenib with bevacizumab in bevacizumab-naive epithelial ovarian cancer (EOC) patients.
  Kohn EC, Lee J, Annunziata CM, Minasian LM, Zujewski J, Prindiville SA, Kotz HL, Squires J, Houston ND, Chen HX, Wright JJ> ;J. Clin. Oncol.. 2011-05-20
• Standard terms of agreement for research trials (START): A joint National Cancer Institute (NCI) and CEO-roundtable Life Sciences Consortium (LSC) project.
  Prindiville SA, Hautala JA, Miller BJ, Shoemaker D, Curt GA, Porter PD, Doroshow JH> ;J. Clin. Oncol.. 2011-05-20
• Phase I study of the PARP inhibitor olaparib (O) in combination with carboplatin (C) in BRCA1/2 mutation carriers with breast (Br) or ovarian (Ov) cancer (Ca).
  Lee J, Annunziata CM, Minasian LM, Zujewski J, Prindiville SA, Kotz HL, Squires J, Houston ND, Ji JJ, Yu M, Doroshow JH, Kohn EC> ;J. Clin. Oncol.. 2011-05-20
• 2 citations
  Interphase cytogenetics of sputum cells for the early detection of lung carcinogenesis.
  Sheila A. Prindiville, Thomas Ried> ;Cancer Prevention Research. 2010 Apr 1
• 32 citations
  Mammographic density does not differ between unaffected BRCA1/2 mutation carriers and women at low-to-average risk of breast cancer.
  Gretchen L. Gierach, Jennifer T. Loud, Catherine Chow, Sheila A. Prindiville, Jennifer Eng-Wong, Peter W. Soballe, Claudia Giambartolomei, Phuong L. Mai, Claudia E. Ga...> ;Breast Cancer Research and Treatment. 2010 Feb 4
• 950 citations
  The Prioritization of Cancer Antigens: A National Cancer Institute Pilot Project for the Acceleration of Translational Research
  Martin A. Cheever, James P. Allison, Andrea S. Ferris, Olivera J. Finn, Benjamin M. Hastings, Toby T. Hecht, Ira Mellman, Sheila A. Prindiville, Jaye L. Viner, Louis M...> ;Clinical Cancer Research. 2009 Sep 1
• 77 citations
  The influence of a gene expression profile on breast cancer decisions.
  Leonard R. Henry, Alexander Stojadinovic, Sandra M. Swain, Sheila A. Prindiville, Rose Cordes, Peter W. Soballe> ;Journal of Surgical Oncology. 2009 May 1
• 13 citations
  Recruitment to a physical activity intervention study in women at increased risk of breast cancer
  Larissa A. Korde, Amy Micheli, Ashley W Smith, David Venzon, Sheila A. Prindiville, Bart Drinkard, Nancy G. Sebring, Marcia D Smith, Jo Anne Zujewski, Jennifer Eng-Wong> ;BMC Medical Research Methodology. 2009 Apr 27
• 22 citations
  Ductal Lavage in Women from BRCA1/2 Families: Is There a Future for Ductal Lavage in Women at Increased Genetic Risk of Breast Cancer?
  Jennifer T. Loud, Anne C. M. Thiébaut, Andrea Abati, Armando C. Filie, Kathryn Nichols, David N. Danforth, Ruthann M. Giusti, Sheila A. Prindiville, Mark H. Greene> ;Cancer Epidemiology, Biomarkers & Prevention. 2009 Apr 1
• 45 citations
  Effect of Raloxifene on Mammographic Density and Breast Magnetic Resonance Imaging in Premenopausal Women at Increased Risk for Breast Cancer
  Jennifer Eng-Wong, Jennifer Orzano-Birgani, Catherine Chow, David Venzon, Jianhua Yao, Claudia E. Galbo, Jo Anne Zujewski, Sheila A. Prindiville> ;Cancer Epidemiology, Biomarkers & Prevention. 2008 Jul 1
• The influence of a gene expression profile on breast cancer decisions.
  Henry LR, Prindiville SA, Swain SM, Cordes R, Soballe M D PW> ;J. Clin. Oncol.. 2008-05-20
• 193 citations
  RAD51 135G→C Modifies Breast Cancer Risk among BRCA2 Mutation Carriers: Results from a Combined Analysis of 19 Studies
  Antonis C. Antoniou, Olga M. Sinilnikova, Jacques Simard, Mélanie Léoné, Martine Dumont, Susan L. Neuhausen, Jeffery P. Struewing, Dominique Stoppa-Lyonnet, Laure Barj...> ;American Journal of Human Genetics. 2007 Dec 1
• 57 citations
  Randomized comparison of phone versus in-person BRCA1/2 predisposition genetic test result disclosure counseling
  Jean Jenkins, Kathleen A. Calzone, Eileen Dimond, David J. Liewehr, Seth M. Steinberg, Oxana Jourkiv, Pam Klein, Peter W. Soballe, Sheila A. Prindiville, Ilan R. Kirsch> ;Genetics in Medicine. 2007 Aug 1
• Join now to see all